These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

73 related items for PubMed ID: 5350077

  • 41. Studies on drug transport by normal human leukocytes.
    Kessel D, Hall TC.
    Biochem Pharmacol; 1967 Dec; 16(12):2395-403. PubMed ID: 6075397
    [No Abstract] [Full Text] [Related]

  • 42. Effect of 5 fluorouracil on the soluble RNA of Trichoderma.
    Gressel J, Galun E.
    Biochem Biophys Res Commun; 1966 Jul 20; 24(2):162-8. PubMed ID: 5965222
    [No Abstract] [Full Text] [Related]

  • 43. Deoxyribosyl exchange activity associated with nucleoside phosphorylase.
    Abrams R, Edmonds M, Libenson L.
    Biochem Biophys Res Commun; 1965 Jul 26; 20(3):310-4. PubMed ID: 5892806
    [No Abstract] [Full Text] [Related]

  • 44. Studies of ribose metabolism. III. The pathway of ribose carbon conversion to glucose in man.
    HIATT HH.
    J Clin Invest; 1958 May 26; 37(5):651-4. PubMed ID: 13539206
    [No Abstract] [Full Text] [Related]

  • 45. Kinetics and mechanisms of drug action of microorganisms XXIII: microbial kinetic assay for fluorouracil in biological fluids and its application to human pharmacokinetics.
    Garrett ER, Hurst GH, Green JR.
    J Pharm Sci; 1977 Oct 26; 66(10):1422-9. PubMed ID: 336866
    [No Abstract] [Full Text] [Related]

  • 46. Nucleoside trypanocides and Trypanosoma congolense.
    Williamson J.
    Trans R Soc Trop Med Hyg; 1970 Oct 26; 64(1):179. PubMed ID: 4392589
    [No Abstract] [Full Text] [Related]

  • 47. The biochemistry of pseudouridine.
    Goldwasser E, Heinrikson RL.
    Prog Nucleic Acid Res Mol Biol; 1966 Oct 26; 5():399-416. PubMed ID: 5337699
    [No Abstract] [Full Text] [Related]

  • 48. Physiological and pharmacological determinants of sensitivity and resistance to 5-fluorouracil in lower animals and man.
    Ardalan B, Cooney D, Macdonald JS.
    Adv Pharmacol Chemother; 1980 Oct 26; 17():289-321. PubMed ID: 7004142
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Effect of guanosine on antitumor activity of fluorinated pyrimidines against P 388 leukemia.
    Iigo M, Hoshi A.
    Cancer Chemother Pharmacol; 1984 Oct 26; 13(2):86-90. PubMed ID: 6235977
    [Abstract] [Full Text] [Related]

  • 54. Potentiation of the chemotherapeutic action of 5'-deoxy-5-fluorouridine in combination with guanosine and related compounds.
    Iigo M, Miwa M, Ishitsuka H, Nitta K.
    Cancer Chemother Pharmacol; 1987 Oct 26; 19(1):61-4. PubMed ID: 3028664
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Influence of ribose donors on the action of 5-fluorouracil.
    Kessel D, Hall TC.
    Cancer Res; 1969 Oct 26; 29(10):1749-54. PubMed ID: 5350077
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Potentiation of the antitumor effect of 5-fluorouracil by some nucleotides, and their possible role in the potentiation.
    Tezuka M, Tamemasa O.
    Jpn J Exp Med; 1983 Jun 26; 53(3):155-63. PubMed ID: 6663806
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.